|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8200 SEK | 0.00% |
|
0.00% | +12.48% |
| 07-08 | Isofol begins final dose cohort | FW |
| 07-08 | Isofol Medical AB Initiates Last Dose Cohort In Ongoing Phase Ib Study With Arfolitixorin | CI |
| Market Cap | 263M 27.73M 23.99M 22.4M 20.55M 38.65M 2.64B 39.26M 103M 1.32B 104M 102M 4.37B | P/E 2026 * |
-4.32x | P/E 2027 * | -27.3x |
|---|---|---|---|---|---|
| Enterprise Value | 161M 16.97M 14.68M 13.71M 12.57M 23.65M 1.61B 24.02M 63.11M 809M 63.72M 62.32M 2.68B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 3.96x |
| Free-Float |
90.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Isofol Medical AB
| Current month | -3.42% | ||
| 1 month | -1.20% | ||
| 3 months | +18.84% | ||
| 6 months | +36.78% | ||
| Current year | +12.48% |
| 1 week | 0.79 |  | 0.85 |
| 1 month | 0.69 | | 0.88 |
| Current year | 0.55 | | 0.99 |
| 1 year | 0.55 | | 0.99 |
| 3 years | 0.45 | | 4.88 |
| 5 years | 0.45 | | 14.44 |
| 10 years | 0.45 | | 33.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Petter Lindqvist
CEO | Chief Executive Officer | 74 | 09/01/2024 |
Margareta Hagman
DFI | Director of Finance/CFO | 60 | 13/08/2024 |
Roger Tell
CEO | Chief Executive Officer | 61 | 22/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Lars Erik Lind
CHM | Chairman | 85 | 01/07/2010 |
Alain Herrera
BRD | Director/Board Member | 76 | 01/01/2018 |
Sten Nilsson
BRD | Director/Board Member | 78 | 04/01/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/12/21 | Sell | 58,767 | 0.0364% | |||
| 10/12/21 | Sell | 58,767 | 0.0364% | |||
| 14/06/21 | Others | Chief Financial Officer | 15,153 | 0.0145% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -4.21% | +25.77% | 27.73M | |
| +0.16% | -1.24% | +59.35% | +21.19% | 317B | |
| +0.10% | +1.05% | +33.29% | -12.76% | 72.2B | |
| +20.24% | +24.93% | +63.94% | +141.90% | 11.7B | |
| +0.63% | +1.87% | -2.19% | -3.95% | 8.45B | |
| +2.28% | +8.10% | -14.26% | -14.00% | 4.75B | |
| +14.37% | +22.10% | +4.25% | +50.44% | 4.38B | |
| +3.60% | +9.66% | -28.04% | +8.36% | 4.26B | |
| +1.88% | +6.74% | +15.55% | +56.04% | 2.77B | |
| +4.26% | +0.31% | +1.17% | +0.23% | 2.26B | |
| Average | +4.89% | +7.04% | +12.89% | +27.32% | 42.8B | |
| Weighted average by Cap. | +1.96% | +0.31% | +51.02% | +18.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 43.33M 4.57M 3.96M 3.69M 3.39M 6.37M 435M 6.47M 17.01M 218M 17.17M 16.79M 721M |
| Net income | -61.25M -6.46M -5.59M -5.22M -4.79M -9.01M -615M -9.15M -24.04M -308M -24.27M -23.74M -1.02B | -40.15M -4.24M -3.66M -3.42M -3.14M -5.9M -403M -6M -15.76M -202M -15.91M -15.56M -668M |
| Net Debt | -102M -10.76M -9.31M -8.69M -7.98M -15M -1.02B -15.24M -40.03M -513M -40.42M -39.53M -1.7B | -91M -9.6M -8.31M -7.76M -7.12M -13.38M -914M -13.6M -35.72M -458M -36.06M -35.27M -1.51B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/08/26 | SEK 0.8200 | 0.00% | 31,635 |
| 07/08/26 | SEK 0.8200 | -0.73% | 116,884 |
| 06/08/26 | SEK 0.8260 | +2.86% | 197,701 |
| 05/08/26 | SEK 0.8030 | -0.12% | 142,514 |
| 04/08/26 | SEK 0.8040 | -1.95% | 281,179 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ISOFOL Stock
Select your edition
All financial news and data tailored to specific country editions
